BPI
RCKT icon

BFC Planning, Inc.’s Rocket Pharmaceuticals RCKT Stock Holding History

BFC Planning, Inc.’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.2K Hold
3,500
– – ﹤0.01% 2435
2026
Q2 		$12K Hold
3,500
– – ﹤0.01% 2277
2026
Q1 		$12.5K Hold
3,500
– – ﹤0.01% 1931
2025
Q4 		$12.3K Hold
3,500
– – ﹤0.01% 1979
2025
Q3 		$11.4K Hold
3,500
– – ﹤0.01% 1849
2025
Q2 		$8.58K Sell
3,500
-112
-3% -$567 ﹤0.01% 1877
2025
Q1 		$24.1K Buy
3,612
+36
+1% +$356 ﹤0.01% 1388
2024
Q4 		$45K Buy
3,576
+21
+0.6% +$316 ﹤0.01% 1147
2024
Q3 		$65.7K Buy
+3,555
New +$72.8K 0.01% 1020

Other funds holding RCKT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Monaco Asset Management
Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

BFC Planning, Inc.'s RCKT Position: Q3 2026 in Review

BFC Planning, Inc. held its Rocket Pharmaceuticals (RCKT) position steady in Q3 2026 at 3,500 shares worth $9.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2435.

BFC Planning, Inc. first reported a position in RCKT in Q3 2024 and has held it in 9 quarters since. The position peaked at $65.7K in Q3 2024. 116 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.

  • BFC Planning, Inc. held 3,500 shares of Rocket Pharmaceuticals worth $9.2K as of Q3 2026.
  • BFC Planning, Inc. left its Rocket Pharmaceuticals share count unchanged in Q3 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q3 2026, its #2435 holding.
  • BFC Planning, Inc. first reported a position in Rocket Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning, Inc.'s Rocket Pharmaceuticals position peaked at $65.7K in Q3 2024.
  • 116 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.

Based on BFC Planning, Inc.'s 13F filing for Q3 2026, filed 13 Nov 2026.